Health & bio

Scancell iSCIB1+ Receives Fast Track 4/28 — Advanced Melanoma

iSCIB1+ immunotherapy granted fast-track designation for advanced melanoma treatment. Follows Opna OPN-6602 (multiple myeloma) April 15 and NextCure SIM0505 (ovarian cancer) April 7 fast tracks.

Primary sources · 1

Oncology News Central

← View the full 2026-04-28 (Tue) issue

What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →